Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
Katarzyna Woźniak(Medical University of Warsaw), Valéria Aoki(Universidade de São Paulo), Johann Bauer(Universität Innsbruck), Sarolta Kárpáti(Semmelweis University), Janet A. Fairley(Medical College of Wisconsin), Philippe Bernard(Hôpital Dupuytren), Russell P. Hall(Duke University), Rüdiger Eming(Philipps University of Marburg), F. Caux(Assistance Publique – Hôpitaux de Paris), Stefan Beissert(University Hospital Carl Gustav Carus), Leena Bruckner‐Tuderman(University Medical Center Freiburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Takashi Hashimoto(Osaka Metropolitan University), Luis A. Díaz(Memorial Sloan Kettering Cancer Center), Branka Marinović(University Hospital Centre Zagreb), P. Joly(Inserm), M. Peter Marinkovich(Stanford University), David Fivenson(Trinity Health Ann Arbor Hospital), Sergei A. Grando(University of California, Irvine), Donna A. Culton(University of North Carolina at Chapel Hill), Vanessa Venning(Churchill Hospital), Cathérine Prost(Université Sorbonne Paris Nord), Giuseppe Cianchini(Istituto Dermopatico dell'Immacolata), Masayuki Amagai(Keio University), John J. Zone(University of Utah), Luca Borradori(University Dermatology), Marcel F. Jonkman(University Medical Center Groningen), Jaehwan Kim(University of Science and Technology), Razzaque Ahmed(Harvard University), Dédée F. Murrell(Sutherland Hospital), Josep E. Herrero‐González(Hospital del Mar Research Institute), David T. Woodley(University of Southern California)
Cited by 1
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
|New England Journal of Medicine|2020|2.9k